ATRX Deficiency Drives Aberrant Type I Interferon Signalling Through cGAS-Dependent Transcriptional Dysregulation
Marie‐Thérèse El‐DaheriD, Eve L. White, Andreas FellasiD, Graeme R. GrimesiD, Simone PelliciariiD, Ge ZhuiD, Tom A Tait, Carolina UggentiiD, Natalie F. BlairiD, Erisa Nita, Philippe Emmanuel GautieriD, Hywel Dunn-DaviesiD, Sophie Glen, Somdutta DhiriD, Mathieu Paul RoderoiD, Gillian RiceiD, Luís SeabraiD, Richard C. ClarkiD, Angie FawkesiD, Joseph A. MarshiD, Minke H. W. HuibersiD, Joost B. KoedijkiD, Erika Van NieuwenhoveiD, John H. LivingstoniD, Evangeline WassmeriD, , Yanick Joseph CrowiD
Abstract
The X-linked -thalassaemia intellectual disability syndrome (ATRX) protein is a chromatin remodeller involved in transcriptional regulation and genome stability. While the importance of ATRX in development and malignancy is well recognised, its role in innate immunity is less well defined. In two unrelated patients demonstrating cerebral white matter disease, learning difficulties and a persistent upregulation of interferon stimulated gene expression in whole blood, we identified the same Y1758C missense substitution in ATRX. Using patient-derived cells, engineered fibroblasts and neuronal models, we show that this substitution, and other loss of function mutations in ATRX, result in enhanced type I interferon signalling through a cGAS-dependent mechanism uncoupled from the DNA sensing activity of cGAS. Loss of ATRX function leads to alterations in the chromatin distribution of DAXX and H3.3, with cGAS essential for the changes in nucleosome composition and gene expression mediated by ATRX deficiency. Thus, our study highlights a previously unrecognized link between ATRX dysfunction and inflammation involving a non-canonical role of cGAS.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 5.36
- Field percentile
- top 4%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ARF1 prevents aberrant type I IFN induction by regulating STING activation and recycling
Maximilian Hirschenberger, Alice Lepelley, … Konstantin M. J. Sparrer·medRxiv·Apr 28, 2023
- Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A
A. Lepelley, E. Della Mina, … Y. J. Crow·bioRxiv·Apr 2, 2021
- Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
S. Hariharan, B. T. Whitfield, … D. M. Ashley·bioRxiv·Apr 20, 2023
- A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defects
Rebekah Tillotson, Keqin Yan, … Monica J. Justice·Human Molecular GeneticsPeer-reviewed·May 12, 2023
- The cGAS-STING pathway is an in vivo modifier of genomic instability syndromes
Marva Bergman, Uri Goshtchevsky, … Itamar Harel·bioRxiv·Oct 16, 2024
- Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling
Abraham Shim, Xiaohan Luan, … John Maciejowski·Human Molecular GeneticsPeer-reviewed·May 22, 2024